Sfoglia per Autore
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin gene transcription
2003-01-01 Foti, D.; Iuliano, R; Chiefari, E.; Brunetti, A.
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans
2003-01-01 Hribal, Ml; Perego, L; Lovari, S; Andreozzi, F; Menghini, R; Perego, C; Finzi, G; Usellini, L; Placidi, C; Capella, C; Guzzi, V; Lauro, D; Bertuzzi, F; Davalli, A; Pozza, G; Pontiroli, A; Federici, M; Lauro, R; Brunetti, A; Folli, F; Sesti, G
A nucleoprotein complex containing Sp1, C/EBPb, and HMGI(Y) controls human insulin receptor gene transcription
2003-01-01 Foti, D.; Iuliano, R; Chiefari, E; Brunetti, A
Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells
2004-01-01 D'Alessandris, C.; Federici, M.; Cardellini, M.; Brunetti, A; Ranalli, M.; DEL GUERRA, S.; Lauro, D.; DEL PRATO, S.; Marchetti, P.; Lauro, R.; Sesti, G.; Andreozzi, F
Effetti molecolari del PPARg e dei tiazolidinedioni (TZD) sull’espressione del recettore dell’insulina (RI): implicazioni fisiopatologiche e cliniche
2005-01-01 V., Costa; F., Paonessa; E., Gulletta; D., Foti; Brunetti, A
Loss of the architectural transcription factor HMGA1 causes insulin-resistant diabetes in humans and mice
2005-01-01 Foti, D.; Chiefari, E.; Fedele, M.; Iuliano, R.; Paonessa, F.; Costa, V.; Brunetti, L.; Croce, C. M.; Brunetti, A
Ruolo del fattore di trascrizione AP2 nell’iperespressione del recettore dell’insulina (RI) nel cancro della mammella
2005-01-01 F., Paonessa; V., Costa; E., Gulletta; D., Foti; Brunetti, A
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice
2005-01-01 Chiefari, E; Fedele, M; Iuliano, R; Brunetti, L; Paonessa, F; Manfioletti, G; Barbetti, F; Croce, Cm; Fusco, A; Brunetti, A; Foti, D.; Brunetti, A
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer
2006-01-01 Paonessa, F.; Costa, V.; Chiefari, E.; Brunetti, G.; Leone, F.; Luciano, F.; Wu, F.; Lee, A. S.; Gulletta, E.; Fusco, A.; Brunetti, A; Foti, D.
Activator protein-2 (AP-2) overexpression leading to increased insulin receptor (IR) expression is a critical event in human breast cancer
2007-01-01 Paonessa, F.; Foti, D.; Chiefari, E.; Costa, V.; Brunetti, G.; Leone, F.; Wu, F.; Lee, A. S.; Gulletta, E.; Fusco, A.; Brunetti, A
Role of insulin receptor in breast cancer: new findings in research and molecular terapy
2007-01-01 Paonessa, F; Brunetti, A
Genetic syndromes of extreme insulin resistance and diabetes mellitus due to defects in insulin receptor gene transcription
2007-01-01 Chiefari, E.; Foti, D.; Iuliano, R.; Brunetti, L.; Paonessa, F.; Brunetti, A
Insulin receptor overexpression in human breast cancer: a new role for the activator protein-2 (ap-2) transcription factor
2008-01-01 F., Paonessa; D., Foti; E., Chiefari; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; G., Brunetti; A. S., Lee; E., Gulletta; A., Fusco; Brunetti, A
The architectural transcription factor Hmga1: a new candidate gene for type 2 diabetes
2008-01-01 E., Chiefari; F., Paonessa; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; C., Capula; L., Palaia; M., Fedele; D., Foti; A., Fusco; Brunetti, A
Antineoplastic effects of PPARg and thiazolidinedione-PPARg agonists
2008-01-01 D., Foti; V., Costa; F., Paonessa; E., Chiefari; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; G., Brunetti; E., Gulletta; A., Fusco; Brunetti, A
The insulin receptor. In Encyclopedia of Cancer, 2nd ed. Springer
2008-01-01 Brunetti, A
A modified quantitative EMSA and its application in the study of RNA-protein interactions
2008-01-01 G., Covello; E., Chiefari; F., Paonessa; A., Nocera; I., LE PERA; S., Iiritano; D., Foti; Brunetti, A
Transcriptional regulation of glucose metabolism: new insights from Hmga1-knockout mice
2008-01-01 E., Chiefari; F., Paonessa; F., Fedele; M., Iritano; I., LE PERA; D., Foti; A., Fusco; Brunetti, A
The insulin receptor: a new anticancer target for the peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione-PPARg agonists
2008-01-01 Costa, V; Paonessa, F; Chiefari, E; Palaia, L; Brunetti, G; Gulletta, E; Fusco, A; Brunetti, A; Foti, Daniela Patrizia Francesca
Endothelial dysfunction: which markers for a laboratory approach?
2009-01-01 V., Ventura; Brunetti, A; E., Gulletta; Greco, M; Foti, D.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A nucleoprotein complex containing Sp1, C/EBP beta, and HMGI-Y controls human insulin gene transcription | 1-gen-2003 | Foti, D.; Iuliano, R; Chiefari, E.; Brunetti, A. | |
Chronic hyperglycemia impairs insulin secretion by affecting insulin receptor expression, splicing, and signaling in RIN beta cell line and human islets of Langerhans | 1-gen-2003 | Hribal, Ml; Perego, L; Lovari, S; Andreozzi, F; Menghini, R; Perego, C; Finzi, G; Usellini, L; Placidi, C; Capella, C; Guzzi, V; Lauro, D; Bertuzzi, F; Davalli, A; Pozza, G; Pontiroli, A; Federici, M; Lauro, R; Brunetti, A; Folli, F; Sesti, G | |
A nucleoprotein complex containing Sp1, C/EBPb, and HMGI(Y) controls human insulin receptor gene transcription | 1-gen-2003 | Foti, D.; Iuliano, R; Chiefari, E; Brunetti, A | |
Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells | 1-gen-2004 | D'Alessandris, C.; Federici, M.; Cardellini, M.; Brunetti, A; Ranalli, M.; DEL GUERRA, S.; Lauro, D.; DEL PRATO, S.; Marchetti, P.; Lauro, R.; Sesti, G.; Andreozzi, F | |
Effetti molecolari del PPARg e dei tiazolidinedioni (TZD) sull’espressione del recettore dell’insulina (RI): implicazioni fisiopatologiche e cliniche | 1-gen-2005 | V., Costa; F., Paonessa; E., Gulletta; D., Foti; Brunetti, A | |
Loss of the architectural transcription factor HMGA1 causes insulin-resistant diabetes in humans and mice | 1-gen-2005 | Foti, D.; Chiefari, E.; Fedele, M.; Iuliano, R.; Paonessa, F.; Costa, V.; Brunetti, L.; Croce, C. M.; Brunetti, A | |
Ruolo del fattore di trascrizione AP2 nell’iperespressione del recettore dell’insulina (RI) nel cancro della mammella | 1-gen-2005 | F., Paonessa; V., Costa; E., Gulletta; D., Foti; Brunetti, A | |
Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice | 1-gen-2005 | Chiefari, E; Fedele, M; Iuliano, R; Brunetti, L; Paonessa, F; Manfioletti, G; Barbetti, F; Croce, Cm; Fusco, A; Brunetti, A; Foti, D.; Brunetti, A | |
Activator protein-2 overexpression accounts for increased insulin receptor expression in human breast cancer | 1-gen-2006 | Paonessa, F.; Costa, V.; Chiefari, E.; Brunetti, G.; Leone, F.; Luciano, F.; Wu, F.; Lee, A. S.; Gulletta, E.; Fusco, A.; Brunetti, A; Foti, D. | |
Activator protein-2 (AP-2) overexpression leading to increased insulin receptor (IR) expression is a critical event in human breast cancer | 1-gen-2007 | Paonessa, F.; Foti, D.; Chiefari, E.; Costa, V.; Brunetti, G.; Leone, F.; Wu, F.; Lee, A. S.; Gulletta, E.; Fusco, A.; Brunetti, A | |
Role of insulin receptor in breast cancer: new findings in research and molecular terapy | 1-gen-2007 | Paonessa, F; Brunetti, A | |
Genetic syndromes of extreme insulin resistance and diabetes mellitus due to defects in insulin receptor gene transcription | 1-gen-2007 | Chiefari, E.; Foti, D.; Iuliano, R.; Brunetti, L.; Paonessa, F.; Brunetti, A | |
Insulin receptor overexpression in human breast cancer: a new role for the activator protein-2 (ap-2) transcription factor | 1-gen-2008 | F., Paonessa; D., Foti; E., Chiefari; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; G., Brunetti; A. S., Lee; E., Gulletta; A., Fusco; Brunetti, A | |
The architectural transcription factor Hmga1: a new candidate gene for type 2 diabetes | 1-gen-2008 | E., Chiefari; F., Paonessa; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; C., Capula; L., Palaia; M., Fedele; D., Foti; A., Fusco; Brunetti, A | |
Antineoplastic effects of PPARg and thiazolidinedione-PPARg agonists | 1-gen-2008 | D., Foti; V., Costa; F., Paonessa; E., Chiefari; S., Iiritano; I., LE PERA; G., Covello; A., Nocera; G., Brunetti; E., Gulletta; A., Fusco; Brunetti, A | |
The insulin receptor. In Encyclopedia of Cancer, 2nd ed. Springer | 1-gen-2008 | Brunetti, A | |
A modified quantitative EMSA and its application in the study of RNA-protein interactions | 1-gen-2008 | G., Covello; E., Chiefari; F., Paonessa; A., Nocera; I., LE PERA; S., Iiritano; D., Foti; Brunetti, A | |
Transcriptional regulation of glucose metabolism: new insights from Hmga1-knockout mice | 1-gen-2008 | E., Chiefari; F., Paonessa; F., Fedele; M., Iritano; I., LE PERA; D., Foti; A., Fusco; Brunetti, A | |
The insulin receptor: a new anticancer target for the peroxisome proliferator-activated receptor-g (PPARg) and thiazolidinedione-PPARg agonists | 1-gen-2008 | Costa, V; Paonessa, F; Chiefari, E; Palaia, L; Brunetti, G; Gulletta, E; Fusco, A; Brunetti, A; Foti, Daniela Patrizia Francesca | |
Endothelial dysfunction: which markers for a laboratory approach? | 1-gen-2009 | V., Ventura; Brunetti, A; E., Gulletta; Greco, M; Foti, D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile